Price target upside
Edgewise Therapeutics, Inc. Price Target Upside or Downside
EWTX price target upside based on the current price and analyst average.
Direct answer
Edgewise Therapeutics, Inc.'s analyst target implies +15.4%.
The average target is $51.15 compared with a recorded current price of $44.31.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 11, 2026.
Get free Edgewise Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $44.31
- Average price target
- $51.15
- High price target
- $66.00
- Low price target
- $36.00
- Target upside
- +15.4%
- Consensus rating
- Buy
- Analysts
- 13
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026